Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision identifier was updated from v3.5.3 to v3.5.4, indicating a minor update to the published version. This change does not modify visible content or functionality on the page.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange Detected- The page revision was updated from v3.5.2 to v3.5.3, indicating a new site release. This update is metadata-only and does not modify study content or displayed information.SummaryDifference0.1%

- Check41 days agoChange DetectedNo website changes were detected from the provided additions/deletions inputs.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedB-cell chronic lymphocytic leukemia was added to the list of conditions in the study details. This expands the study description to include CLL cohorts.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.